Evidence map›Paper›PMID 28265178›Full record

ArticleMediators of inflammation2017

ADAM19: A Novel Target for Metabolic Syndrome in Humans and Mice.

Lakshini Weerasekera, Caroline Rudnicka, Qing-Xiang Sang, Joanne E Curran, Matthew P Johnson, Eric K Moses, Harald H H Göring, John Blangero, Jana Hricova, Markus Schlaich and 1 more

Open access · goldAbstract read
In one paragraph

Article in Mediators of inflammation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 14 citations in OpenAlex.

  1. ADAM19: biological characteristics and implications in disease pathology and clinical applications.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  2. Article
  3. Article
  4. Journal of diabetes research · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. The Metalloproteinase ADAM28 Promotes Metabolic Dysfunction in Mice.International journal of molecular sciences · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Lakshini WeerasekeraSchool of Medicine and Pharmacology, University of Western Australia, Crawley, Western Australia, Australia.
Caroline RudnickaRoyal Perth Hospital, Perth, Australia.
Qing-Xiang SangDepartment of Chemistry and Biochemistry, Florida State University, Tallahassee, FL, USA.
Joanne E CurranSouth Texas Diabetes & Obesity Institute, University of Texas Rio Grande Valley School of Medicine, Brownsville, TX, USA.ORCID 0000-0002-6898-155X
Matthew P JohnsonSouth Texas Diabetes & Obesity Institute, University of Texas Rio Grande Valley School of Medicine, Brownsville, TX, USA.
Eric K MosesCentre for Genetic Origins of Health & Diseases, Faculty of Medicine, Dentistry & Health Sciences, University of Western Australia and Faculty of Health Sciences, Curtin University, Western Australia, Australia.
Harald H H GöringSouth Texas Diabetes & Obesity Institute, University of Texas Rio Grande Valley School of Medicine, Brownsville, TX, USA.
John BlangeroSouth Texas Diabetes & Obesity Institute, University of Texas Rio Grande Valley School of Medicine, Brownsville, TX, USA.
Jana HricovaSchool of Medicine and Pharmacology, University of Western Australia, Crawley, Western Australia, Australia.
Markus SchlaichSchool of Medicine and Pharmacology, University of Western Australia, Crawley, Western Australia, Australia; Royal Perth Hospital, Perth, Australia.
Vance B MatthewsSchool of Medicine and Pharmacology, University of Western Australia, Crawley, Western Australia, Australia.ORCID 0000-0003-3955-3692
The University of Western Australia · AUThe University of Texas Rio Grande Valley · USFlorida State University · USRoyal Perth Hospital · AU

Funding

Quantitative Trait Locus Mapping in Human PedigreesR37MH059490 · NIMH · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI BLANGERO, JOHN · 2001 to 2010
$6.8M
High Performance Computing System for Human GenomicsS10RR029392 · NCRR · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI BLANGERO, JOHN · 2010 to 2010
$2.1M
QUANTITATIVE TRAIT LOCUS MAPPING IN HUMAN PEDIGREESR01MH059490 · NIMH · SOUTHWEST FOUNDATION FOR BIOMEDICAL RES · PI BLANGERO, JOHN · 1998 to 2000
$426k
MOLECULAR AND BIOCHEMICAL GENETICS LABORATORY RENOVATIONC06RR013556 · NCRR · SOUTHWEST FOUNDATION FOR BIOMEDICAL RES · PI SHADE, ROBERT E · 1998 to 1998
–
NCRR NIH HHS C06 RR013556NCRR NIH HHS S10 RR029392NIMH NIH HHS R01 MH059490NIMH NIH HHS R37 MH059490
6 · The paper itself

Abstract

Obesity is one of the most prevalent metabolic diseases in the Western world and correlates directly with insulin resistance, which may ultimately culminate in type 2 diabetes (T2D). We sought to ascertain whether the human metalloproteinase A Disintegrin and Metalloproteinase 19 (ADAM19) correlates with parameters of the metabolic syndrome in humans and mice. To determine the potential novel role of ADAM19 in the metabolic syndrome, we first conducted microarray studies on peripheral blood mononuclear cells from a well-characterised human cohort. Secondly, we examined the expression of ADAM19 in liver and gonadal white adipose tissue using an in vivo diet induced obesity mouse model. Finally, we investigated the effect of neutralising ADAM19 on diet induced weight gain, insulin resistance in vivo, and liver TNF-

Indexed as

ADAM ProteinsAnimalsDiet, High-FatHumansInsulin ResistanceLeukocytes, MononuclearLiverMaleMetabolic SyndromeMiceMice, Inbred C57BLRNA, Small InterferingTumor Necrosis Factor-alphaADAM19 protein, humanAdam19 protein, mouseADAM ProteinsRNA, Small InterferingTumor Necrosis Factor-alpha

Identifiers

PMID28265178
PMCPMC5318628
OpenAlexW2587056477

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.